Recombinant LAG3 (Relatlimab Biosimilar) antibody
The Human Monoclonal anti-LAG3 (Relatlimab Biosimilar) antibody is suitable to detect LAG3 (Relatlimab Biosimilar) in samples from Human.
Catalog No. ABIN7597942
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant LAG3 (Relatlimab Biosimilar) antibody (ABIN7597942)
Target
LAG3 (Relatlimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This LAG3 (Relatlimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Relatlimab Biosimilar Antibody
-
Specificity
- FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
anti-LAG3 (Relatlimab Biosimilar) antibody
Research Grade Reactivity: Human FACS, ELISA Host: Human Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 7.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- LAG3 (Relatlimab Biosimilar)
-
Alternative Name
- Relatlimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3
-
UniProt
- P18627
-
CAS-No
- 1673516-98-7
Target
-
You are here:
